Stretch Marks Treatment Market

Market Overview:

The global stretch marks treatment market size reached USD 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The market is primarily driven by rising cosmetic concerns among individuals, increasing prevalence of obesity, significant investments in dermatological research, and growing influence of social media on body image and personal care trends.

Stretch marks are scars or irregular lines that develop when the skin stretches or shrinks suddenly. They are widely caused by unexpected changes in the body that cause the collagen and elastin to rupture and as the skin heals naturally, stretch marks occur. They are also caused by Cushing syndrome, abnormal collagen formation and Ehlers-danlos syndrome. Stretch marks are common in pregnant women and individuals with rapid changes in muscle size due to significant weight gain or weight loss. Some of the commonly used stretch mark treatment solutions include lotions, creams, pulse-dye lasers, fractional lasers, oil and serums. They aid in reducing the visibility of stretch marks by rebuilding collagen for tightening the skin and treating open pores and fine lines.

Stretch Marks Treatment Market Trends:

Growing Cosmetic Surgery Industry

The growth in the cosmetic surgery industry significantly impacts the stretch marks treatment market, as evidenced by an increasing preference for non-surgical procedures. Additionally, with advances in minimally invasive technologies, there is less downtime and more accessible options available for individuals who wish to enhance their cosmetic characteristics. Moreover, the popular treatments include laser therapy, microdermabrasion, and chemical peels that are increasingly used to eliminate imperfections while improving the skin. This is driven by consumer demand for the treatments that bring the effects and eliminate the risks and recovery time that accompany surgeries. Besides, the widespread adoption of cosmetic procedures is due to the minimization of stigma, which is driving individuals to indulge in these procedures, thus driving stretch mark treatments market growth.

Rising Obesity Rates

The growing obesity rates worldwide are another critical driver for the stretch marks treatment market. According to Centers for Disease Control and Prevention (CDC) data from 2023 reveals that in 23 states, over one-third of adults (35%) are now classified as obese. Over a decade ago, no state reported an obesity rate of 35% or higher. Currently, every state in the U.S. has at least 20% of its adult population living with obesity. Additionally, frequent weight fluctuations, a common consequence of obesity, can lead to the formation of stretch marks. This creates a robust demand for effective treatment solutions that can minimize their appearance. Besides, the beauty and wellness industries are developing marketing products and procedures that cater specifically to this need. Along with this, from topical creams and oils to advanced laser therapies, the market is expanding to include a wide range of options catering to different preferences and budgets. This response reflects the growing issue of obesity and aligns with a broader consumer shift toward personal care and body positivity, emphasizing the treatment of conditions like stretch marks more openly and innovatively across the globe.

Growing Medical Aesthetic Procedures

The increase in medical aesthetic procedures, particularly non-invasive ones, also plays a crucial role in the expansion of the stretch marks treatment market. Additionally, with advancements in medical technology, treatments that were once considered complex and invasive are now more accessible and convenient. Moreover, non-invasive treatments like laser therapy and microdermabrasion are preferred for their efficacy in reducing the visibility of stretch marks without the need for surgical intervention. This shift toward gentler, technologically advanced solutions aligns with the modern consumer's lifestyle, which often prioritizes minimal recovery time. Besides, the aesthetic appeal of these procedures, coupled with their promoted benefits, has led to wider acceptance and subsequent demand, fueling market growth in regions with a high uptake of cosmetic procedures.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global stretch marks treatment market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on treatment, distribution channel and end user.

Breakup by Treatment:

• Topical Products
  • Creams
  • Oils and Serum
  • Lotions
• Lasers
  • Fractional Lasers
  • Pulse-Dye Lasers
  • Others
• Microdermabrasion
• Others
   

Breakup by Distribution Channel:

• Institutional
• Retail
  • Supermarkets and Hypermarkets
  • Specialist Retailers
  • Medical Retailers
  • Online Stores
  • Others
     

Breakup by End User:

• Hospitals and Clinics
• Home Use
• Specialty Dermatology Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda.

Stretch Marks Treatment Market News:

• In January 2024, Cynosure, and Hahn & Company completed the acquisition of Lutronic and announced a definitive merger agreement to strategically combine Cynosure and Lutronic. Both firms are international suppliers of energy-based medical aesthetic treatment systems and associated technologies. The merger is anticipated to be finalized in the first quarter of 2024, pending standard closing conditions.

Report Coverage: